本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Inhibrx Biosciences

109.27
-2.1500-1.93%
盤後109.270.00000.00%19:30 EDT
成交量:21.10萬
成交額:2,341.92萬
市值:16.03億
市盈率:-12.31
高:115.11
開:113.00
低:108.93
收:111.42
52周最高:155.29
52周最低:26.19
股本:1,467.12萬
流通股本:863.89萬
量比:0.35
換手率:2.44%
股息:- -
股息率:- -
每股收益(TTM):-8.8768
每股收益(LYR):-9.0434
淨資產收益率:-1773.60%
總資產收益率:-43.61%
市淨率:-30.26
市盈率(LYR):-12.08

資料載入中...

2026/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/08

重要事件披露

Form 8-K - Current report
2026/08/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

重要事件披露

Form 8-K - Current report
2026/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/16

重要事件披露

Form 8-K - Current report
2026/06/15

重要事件披露

Form 8-K - Current report
2026/06/03

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

重要事件披露

Form 8-K - Current report
2026/05/11

重要事件披露

Form 8-K - Current report
2026/04/21

重要事件披露

Form 8-K - Current report
2026/03/19

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]